TickerFacts.

Company research / INCY

Incyte Corp (INCY)

Build a valuation ↗↓ Download CSV

SEC name INCYTE CORP · CIK 0000879169 · Nasdaq · Services-Commercial Physical & Biological Research

  • Sector Services
  • Incorporated DE
  • Fiscal year ends Dec 31

For the year ended 2025-12-31, Incyte Corp reported revenue of $5.14B. Revenue grew 21.2% from the prior annual period. Over the twelve months to 2026-03-31, revenue was $5.36B.

Key ratios (year ended 2025-12-31)

92.8%
Gross margin (computed)
29.5%
Operating margin
25.0%
Net margin
24.9%
Return on year-end equity
21.2%
Revenue growth (YoY)

Computed by TickerFacts from revenue minus cost of revenue. This may differ from the issuer's reported gross profit or margin; check the revenue and cost definitions.

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 4 (ownership change) · 2026-10-19

Headquarters locality: Wilmington · View on map

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

The first column covers the twelve months to 2026-03-31 from the latest quarterly report: flows are the last fiscal year plus this year to date minus the same months a year earlier, and balances are as of that date. Per-share figures are annual only.

Period endedTTM to
2026-03-31		2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
Revenue$5.36B$5.14B$4.24B$3.70B$3.39B$2.99B$2.67B$2.16B$1.88B$1.54B$1.11B
Cost of Revenue$403.46M$372.13M$312.07M$254.99M$207.00M$150.99M$131.33M$114.25M$94.12M$79.48M$58.19M
Gross Profit (computed)$4.96B$4.77B$3.93B$3.44B$3.19B$2.84Bn/a$2.04B$1.79B$1.46B$1.05B
R&D Expense$2.13B$2.05B$2.61B$1.63B$1.59B$1.46B$2.22B$1.15B$1.20B$1.33B$581.86M
Operating Income$1.61B$1.51B$61.37M$620.52M$579.44M$585.78M-$263.68M$402.01M$129.22M-$243.39M$145.00M
Depreciation & Amortization$94.73M$93.29M$89.25M$82.66M$67.86M$57.84M$51.81M$54.53M$54.97M$52.18M$58.42M
EBITDA$1.71B$1.61B$150.61M$703.18M$647.29M$643.62M-$211.87M$456.54M$184.19M-$191.21M$203.42M
Net Income$1.43B$1.29B$32.62M$597.60M$340.66M$948.58M-$295.70M$446.91M$109.49M-$313.14M$104.22M
EPS (Diluted)n/a$6.41$0.15$2.65$1.52$4.27-$1.36$2.05$0.51-$1.53$0.54
Total Assets$7.34B$6.96B$5.44B$6.78B$5.84B$4.93B$3.56B$3.43B$2.65B$2.30B$1.64B
Total Liabilities$1.72B$1.79B$2.00B$1.59B$1.47B$1.16B$949.65M$828.34M$719.79M$671.95M$1.22B
Long-Term Debtn/an/an/an/an/an/an/an/a$19.09B$26.80M$749.80M
Shareholders' Equity$5.62B$5.17B$3.45B$5.19B$4.37B$3.77B$2.61B$2.60B$1.93B$1.63B$419.47M
Cash & Equivalents$3.46B$3.10B$1.69B$3.21B$2.95B$2.06B$1.51B$1.83B$1.16B$899.51M$652.34M
Operating Cash Flow$1.52B$1.41B$335.34M$496.49M$969.94M$749.49M-$124.60M$710.66M$336.23M-$92.99M$304.76M
Capital Expendituresn/an/an/an/a$77.83M$181.01M$187.38M$78.06M$73.48M$111.02M$120.28M
Free Cash Flown/an/an/an/a$892.11M$568.48M-$311.98M$632.59M$262.74M-$204.01M$184.48M
Share Repurchasesn/a$0$2.00B$0$0n/an/an/an/an/an/a
Shares Outstanding199.95M198.46M193.43M224.29M222.75M221.08M219.49M216.18M213.27M211.26M188.85M
Weighted Average Diluted Sharesn/a200.70M210.53M225.93M223.96M222.07M218.07M217.66M215.63M204.58M194.12M
EPS (Basic)n/a$6.59$0.16$2.67$1.53$4.30-$1.36$2.08$0.52-$1.53$0.55

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView